Solara Active Pharma Sciences Ltd.

NSE: SOLARA | BSE: 541540

₹579.90

up-down-arrow72.20 (14.22%)

As on 15-May-2026IST

Market cap

info icon

₹2,791 Cr

Revenue (TTM)

info icon

₹1,369 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

2.2

Div. Yield

info icon

0 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score1/10

Growth Score fund-quick-summary-circle

Growth Score5/10

Valuation Score fund-quick-summary-circle

Valuation Score2/10

Momentum Score fund-quick-summary-circle

Momentum Score6/10

Solara Active Share Price

Compare

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Stock Range

Today’s Range

Low: 502.00 High: 598.50

52 Week Range

Low: 422.00 High: 734.40

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹-7 Cr

  • ROEROE information

    0.1 %

  • ROCEROCE information

    6.1 %

  • Industry P/EIndustry P/E information

    38.14

  • EV/EBITDAEV/EBITDA information

    17.7

  • Debt to EquityDebt to Equity information

    0.1

  • Book ValueBook Value information

    ₹257.6

  • EPSEPS information

    ₹-0.3

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    48,171,562

8 Years Aggregate

CFO

₹849.07 Cr

EBITDA

₹1,253.56 Cr

Net Profit

₹-238.03 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Solara Active
2.6 19.6 16.1 0.7 15.6 -18.2 --
BSE Healthcare
8.7 11.0 10.7 11.7 26.8 14.4 11.8
As on 15-May-2026
Company
2025
2024
2023
2022
2021
2020
2019
Solara Active
-19.5 105.0 -16.1 -57.8 -14.9 179.1 40.6
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8 32.1 -6.8
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9 61.4 -3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

*All values are in (₹ Cr)

*All values are in (₹ Cr)

*All values are in (₹ Cr)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Solara Active
579.9 2,791.3 1,369.0 -7.4 6.4 -0.1 -- 2.2
1,044.6 12,824.4 2,551.8 564.5 28.3 18.4 22.7 3.8
430.4 7,458.2 1,053.1 293.6 32.3 24.6 25.4 5.8
1,135.3 11,839.4 1,158.7 309.6 31.9 17.3 37.9 6.3
1,704.9 32,273.8 9,203.5 941.3 15.4 19.6 34.9 6.5
370.3 4,048.6 159.3 47.8 39.0 18.6 84.7 14.6
16,590.0 21,132.6 2,023.0 364.0 23.9 20.8 58.1 11.3
1,050.4 4,831.3 649.5 121.6 23.7 13.2 41.9 5.2
649.0 7,364.3 502.0 138.7 -- 32.8 53.1 8.5
211.2 5,588.2 7.1 -276.3 -4,077.5 -63.3 -- 9.4

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Solara Active

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America,...  South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, anti-hyperkalaemia, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical development, impurity synthesis, and regulatory support. In addition, the company exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.  Read more

  • Incorporated

    2017

  • Chairman

    R Ramakrishnan

  • Managing Director

    Sandeep Rao

  • Headquarters

    Navi Mumbai, Maharashtra

  • Website

    www.solara.co.in

Edit peer-selector-edit

FAQs for Solara Active

The share price of Solara Active Pharma Sciences Ltd is ₹579.90 (NSE) and ₹579.45 (BSE) as of 15-May-2026 IST. Solara Active Pharma Sciences Ltd has given a return of 15.6% in the last 3 years.

Since, TTM earnings of Solara Active Pharma Sciences Ltd is negative, P/E ratio is not available.
The P/B ratio of Solara Active Pharma Sciences Ltd is 2.25 times as on 15-May-2026, a 22 discount to its peers’ median range of 2.89 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
3,820.42
1.89
2024
0.00
1.44
2023
0.00
0.79
2022
0.00
1.57
2021
22.63
3.16

The 52-week high and low of Solara Active Pharma Sciences Ltd are Rs 734.40 and Rs 422.00 as of 15-May-2026.

Solara Active Pharma Sciences Ltd has a market capitalisation of ₹ 2,791 Cr as on 15-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Solara Active Pharma Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.